Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease.
Nuvoli B, Germoni S, Morosetti C, Santoro R, Cortese G, Masi S, Cordone I, Galati R. Nuvoli B, et al. Mol Cancer. 2014 Mar 21;13:69. doi: 10.1186/1476-4598-13-69. Mol Cancer. 2014. Retraction in: Mol Cancer. 2022 Dec 9;21(1):214. doi: 10.1186/s12943-022-01692-9 PMID: 24655565 Free PMC article. Retracted.
Reactive oxygen species a double-edged sword for mesothelioma.
Benedetti S, Nuvoli B, Catalani S, Galati R. Benedetti S, et al. Among authors: nuvoli b. Oncotarget. 2015 Jul 10;6(19):16848-65. doi: 10.18632/oncotarget.4253. Oncotarget. 2015. PMID: 26078352 Free PMC article. Review.
17 results